RxDoctor Payments Data

Wesley Schermer, DO

Family Medicine · Spring Lake, MINPI 1043878804

Payments from drug & device makers

$303in general payments, 2019–2025

Across 11 payments — averaging $27.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$92
  • Novartis$49
  • Amgen$45
  • Novo Nordisk$36
  • AbbVie$30
  • AstraZeneca$25
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$303 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$27,894
Medicare patients
113
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban169$160,412
TrulicityDulaglutide88$97,379
OzempicSemaglutide58$78,224
JardianceEmpagliflozin41$58,849
JanuviaSitagliptin Phosphate28$41,849
MounjaroTirzepatide34$35,097
Stiolto RespimatTiotropium Br/Olodaterol Hcl35$22,032
XareltoRivaroxaban12$18,860
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$15,883
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$13,456
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$13,122
Incruse ElliptaUmeclidinium Bromide19$8,862
Spiriva RespimatTiotropium Bromide14$8,124
Atorvastatin Calcium428$7,055
Advair HfaFluticasone Propion/Salmeterol16$6,334

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$160,412169 claims
Novo NordiskOzempic$36$78,22458 claims
AstraZenecaSymbicort$25$4,25911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Spring Lake

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →